Revelation Historical Balance Sheet
| REVBW Stock | USD 0.01 0.0004 3.33% |
Trend analysis of Revelation Biosciences balance sheet accounts such as Non Current Assets Total of 61.8 K, Non Currrent Assets Other of 60.8 K, Common Stock Shares Outstanding of 240.1 K or Liabilities And Stockholders Equity of 12.8 M provides information on Revelation Biosciences' total assets, liabilities, and equity, which is the actual value of Revelation Biosciences to its prevalent stockholders. By breaking down trends over time using Revelation Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Revelation Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Revelation Biosciences is a good buy for the upcoming year.
Revelation |
About Revelation Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Revelation Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Revelation Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Revelation Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Revelation currently owns. An asset can also be divided into two categories, current and non-current.
Revelation Biosciences Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Revelation Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Revelation Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Revelation Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Revelation Biosciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most accounts from Revelation Biosciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Revelation Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.At this time, Revelation Biosciences' Total Assets are fairly stable compared to the past year. Total Stockholder Equity is likely to climb to about 7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 2.9 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 1.5M | 3.9M | 4.2M | 2.2M | Total Assets | 2.0M | 5.5M | 12.2M | 12.8M |
Revelation Biosciences balance sheet Correlations
Click cells to compare fundamentals
Revelation Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.